MAXCYTE INC. - COMMON
Н/д
31-декабря-69 18:00:00
15 мин. задержка
Акции
Н/д
Сегодняшний диапазон
Н/д - Н/д
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
16 сен 2024 01:00:00 Источник Nasdaq GlobeNewswire
-
MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing Conference
05 сен 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
06 авг 2024 15:05:01 Источник Nasdaq GlobeNewswire
-
MaxCyte to Report Second Quarter 2024 Financial Results on August 6, 2024
09 июл 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
MaxCyte to Participate in William Blair 44th Annual Growth Stock Conference
29 май 2024 07:05:00 Источник Nasdaq GlobeNewswire
-
22 май 2024 07:05:00 Источник Nasdaq GlobeNewswire
-
MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance
07 май 2024 15:05:01 Источник Nasdaq GlobeNewswire
-
MaxCyte to Report First Quarter 2024 Financial Results on May 7, 2024
10 апр 2024 07:05:00 Источник Nasdaq GlobeNewswire
-
02 апр 2024 07:05:00 Источник Nasdaq GlobeNewswire
-
MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
12 мар 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary Results
04 мар 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
09 фев 2024 07:05:00 Источник Nasdaq GlobeNewswire
-
30 янв 2024 07:05:00 Источник Nasdaq GlobeNewswire
-
MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs
23 янв 2024 07:05:00 Источник Nasdaq GlobeNewswire
-
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Results
08 янв 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
MaxCyte and Lion TCR form Partnership to Support Global Expansion of Lion TCR's TCR-T Cell Pipeline
03 янв 2024 07:05:00 Источник Nasdaq GlobeNewswire
-
MaxCyte Confirms Appointment of Maher Masoud as President, Chief Executive Officer and Director
02 янв 2024 01:00:00 Источник Nasdaq GlobeNewswire
-
MaxCyte Announces CEO Transition and Updates Revenue Guidance for 2023
11 дек 2023 15:05:00 Источник Nasdaq GlobeNewswire
-
MaxCyte Joins the Alliance for mRNA Medicines (AMM) as a Founding Member
16 ноя 2023 07:05:00 Источник Nasdaq GlobeNewswire
-
MaxCyte Reports Third Quarter 2023 Financial Results and Reiterates Full Year 2023 Revenue Guidance
08 ноя 2023 15:05:01 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >